These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
487 related items for PubMed ID: 12765058
1. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas]. Longchampt E, Lebret T, Molinie V, Bieche I, Botto H, Lidereau R. Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058 [Abstract] [Full Text] [Related]
2. Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas. Longchampt E, Lebret T, Molinie V, Bieche I, Botto H, Lidereau R. BJU Int; 2003 Apr; 91(6):567-72. PubMed ID: 12656916 [Abstract] [Full Text] [Related]
3. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer. Bowles L, Bialkowska-Hobrzanska H, Bukala B, Nott L, Razvi H. Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669 [Abstract] [Full Text] [Related]
4. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer. Takihana Y, Tsuchida T, Fukasawa M, Araki I, Tanabe N, Takeda M. Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859 [Abstract] [Full Text] [Related]
5. hTERT expression in sporadic renal cell carcinomas. Paradis V, Bièche I, Dargère D, Bonvoust F, Ferlicot S, Olivi M, Lagha NB, Blanchet P, Benoît G, Vidaud M, Bedossa P. J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100 [Abstract] [Full Text] [Related]
6. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. Poremba C, Heine B, Diallo R, Heinecke A, Wai D, Schaefer KL, Braun Y, Schuck A, Lanvers C, Bànkfalvi A, Kneif S, Torhorst J, Zuber M, Köchli OR, Mross F, Dieterich H, Sauter G, Stein H, Fogt F, Boecker W. J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877 [Abstract] [Full Text] [Related]
7. Quantitative analysis of hTERT mRNA expression in colorectal cancer. Niiyama H, Mizumoto K, Sato N, Nagai E, Mibu R, Fukui T, Kinoshita M, Tanaka M. Am J Gastroenterol; 2001 Jun; 96(6):1895-900. PubMed ID: 11419845 [Abstract] [Full Text] [Related]
12. Telomerase activity and hTERT mRNA expression in body fluids. Yamamoto Y, Hirakawa E. Diagn Cytopathol; 2005 Mar; 32(3):167-70. PubMed ID: 15690332 [Abstract] [Full Text] [Related]
13. Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues. Yano Y, Yoshida K, Osaki A, Toge T, Tahara H, Ide T, Yasui W. Anticancer Res; 2002 Mar; 22(6C):4101-7. PubMed ID: 12553039 [Abstract] [Full Text] [Related]
16. Human telomerase catalytic subunit gene re-expression is an early event in oral carcinogenesis. Luzar B, Poljak M, Marin IJ, Eberlinc A, Klopcic U, Gale N. Histopathology; 2004 Jul; 45(1):13-9. PubMed ID: 15228439 [Abstract] [Full Text] [Related]
17. Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR. Xie XY, Yang X, Zhang JH, Liu ZJ. Ann Clin Biochem; 2007 Nov; 44(Pt 6):523-8. PubMed ID: 17961306 [Abstract] [Full Text] [Related]